Abiomed Overview
- Year Founded
-
1981
- Status
-
Acquired/Merged
- Employees
-
2,336
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
20
Abiomed General Information
Description
Developer of medical devices that provides circulatory and respiratory support by enabling the heart to rest and recover by improving blood flow and temporarily assisting with the pumping function. The company offers temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
Contact Information
Website
www.abiomed.com(Operating Subsidiary)
Corporate Office
- 22 Cherry Hill Drive
- Danvers, MA 01923
- United States
Corporate Office
- 22 Cherry Hill Drive
- Danvers, MA 01923
- United States
Abiomed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Abiomed Comparisons
Industry
Financing
Details
Abiomed Competitors (50)
One of Abiomed’s 50 competitors is BiVACOR, a Venture Capital-Backed company based in Huntington Beach, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BiVACOR | Venture Capital-Backed | Huntington Beach, CA | ||||
| OrganOx | Private Equity-Backed | Oxford, United Kingdom | ||||
| RenalGuard | Venture Capital-Backed | Milford, MA | ||||
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| Carmat | Formerly PE-Backed | Velizy Villacoublay, France |
Abiomed Patents
Abiomed Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250099739-A1 | Method and apparatus for delivering an oxygenated fluid | Pending | 21-Sep-2023 | ||
| US-20250090826-A1 | Systems and method for improved surgical or graft access | Pending | 20-Sep-2023 | ||
| US-20250065102-A1 | Methods and apparatus for predicting decoupling during non-cardiac medical procedures | Pending | 22-Aug-2023 | ||
| US-20250041579-A1 | Access device with dual entry ports | Pending | 31-Jul-2023 | ||
| US-20250041568-A1 | Echogenic guidewire | Pending | 31-Jul-2023 | A61M25/09 |
Abiomed Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Abiomed Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Abiomed Investments & Acquisitions (20)
Abiomed’s most recent deal was a Later Stage VC with Vivasure Medical for . The deal was made on 14-Mar-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vivasure Medical | 14-Mar-2023 | Later Stage VC | Surgical Devices | ||
| Impulse Dynamics | 23-May-2022 | Later Stage VC | Therapeutic Devices | ||
| PreCardia | 28-May-2021 | Merger/Acquisition | Other Devices and Supplies | ||
| Magenta Medical | 19-Apr-2021 | Later Stage VC | Therapeutic Devices | ||
| CathWorks | 16-Dec-2020 | Later Stage VC | Decision/Risk Analysis |
Abiomed Exits (3)
Abiomed’s most recent exit was on 11-Mar-2019 from ShockWave Medical. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| ShockWave Medical | 11-Mar-2019 | Completed |
|
||
| ShockWave Medical | 12-Dec-2018 | Completed |
|
||
| ALung | 12-Dec-2017 | Later Stage VC | Completed |
|
Abiomed FAQs
-
When was Abiomed founded?
Abiomed was founded in 1981.
-
Where is Abiomed headquartered?
Abiomed is headquartered in Danvers, MA.
-
What is the size of Abiomed?
Abiomed has 2,336 total employees.
-
What industry is Abiomed in?
Abiomed’s primary industry is Therapeutic Devices.
-
Is Abiomed a private or public company?
Abiomed is a Private company.
-
What is the current valuation of Abiomed?
The current valuation of Abiomed is .
-
What is Abiomed’s current revenue?
The current revenue for Abiomed is .
-
How much funding has Abiomed raised over time?
Abiomed has raised $20.1M.
-
Who are Abiomed’s investors?
Balasa Dinverno Foltz, Cutler Investment Group, EW Healthcare Partners, Forbion, and Foundation For The National Institutes Of Health are 5 of 7 investors who have invested in Abiomed.
-
Who are Abiomed’s competitors?
BiVACOR, OrganOx, RenalGuard, Globus Medical, and Carmat are some of the 50 competitors of Abiomed.
-
When was Abiomed acquired?
Abiomed was acquired on 22-Dec-2022.
-
Who acquired Abiomed?
Abiomed was acquired by Johnson & Johnson.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
